












Normal anatomy & histology!!
• Paired intrathoracic organs → lobes
• Right → 3 lobes
• Left → 2 lobes
Robbins and Cotrans Atlas of Pathology 3rd ed, 2015
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– Type I (respiration) 










• Loss of lung volume →
inadequate expansion
• Mechanism:





– Compression: accumulation 
fluid, blood, air → pleural 
cavity. 
– Contraction/ cicatrization: 
local/ generalized fibrotic
Robbins Basic Pathology 9th ed, 2015
Acute Lung Injury (ALI) –
Acute Respiratory Distress Syndrome 
(ARDS)
• Abrupt onset, significant 
hypoxemia
• Bilateral pulmonary 
infiltrate
• Epithelial/ pneumocytes 
– endothelial injury
• Severe ALI → ARDS 
(acute respiratory 
distress syndrome)
• Histopathology: Diffuse 
alveolar damage (DAD)
Robbins Basic Pathology 9th ed, 2015
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• Left: ALI & ARDS – pink hyaline membrane
• Right: healing stage – type II pneumocyte





• Emphysema → COPD
• Chronic bronchitis → COPD
• Asthma
• Bronchiectasis
Robbins Basic Pathology 9th ed, 2015
Emphysema
• Irreversible/ permanent 
enlargement
• Walls destruction, fibrosis (-)
• Distal terminal bronchiole
• Subtypes: 
– Centriacinar (smoking related)
– Panacinar (α1-antitrypsin def)
– Distal acinar
– Irregular 
Robbins Basic Pathology 9th ed, 2015
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Emphysema
HE 40X
Robbins Basic Pathology 9th ed, 2015
Chronic bronchitis
• Persistent & Productive cough 3 months, 2 consecutive years
• Cigarette smoking, air pollutant




• Intermitten and reversible airway obstruction
• Chronic inflammation with eosinophils
• Smooth muscle hypertrophy and 
hyperreactivity
• Increased mucus secretion 
• Significant incidence increase in western 
world → “Hygiene Hypothesis”
Asthma
Robbins Basic Pathology 9th ed, 2015
Robbins Basic Pathology 9th ed, 2015
Bronchiectasis
• Obstruction and chronic persistent infection
• Destruction: muscle – elastic tissue
• Permanent dilation: bronchi – bronchioles 
• Secondary: post pneumonia, TB
Robbins Basic Pathology 9th ed, 2015
Pulmonary Infection
PNEUMONIA
• 1/6 all deaths in US, Indonesia?
• Local defense compromised:
– Loss/ suppression cough reflex (coma, anesthesia, drug) →
aspirated gastric content
– Injury mucociliary (cigarette smoke, viral disease)
– Accumulation of secretion (bronchial obstruction)
– Interference phagocytic/ bactericidal action of alveolar 
macrophages (alcohol, tobacco smoke)
– Pulmonary congestion and edema
• Streptococcus pneumonia > 90%
• Bronchopneumonia – lobar pneumonia
• Anatomic n radiologic
BLURRY…..
Classify – etiology or clinical settings 
Robbins Basic Pathology 9th ed, 2015
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CAP - HAP
• Community acquired pneumonia
S. pneumonia, H. influenzae,….
• Hospital acquired pneumonia
P. aeruginosa, K. pneumonia,….




Morphology: congestion – red hepatization –
gray hepatization – resolution
Pneumonia








• Chronic granulomatous disease
• Lung – extrapulmonal
Robbins Basic Pathology 9th ed, 2015
Lung Tumors
GLOBOCAN, 2018







• Benign - malignant, epithelial – mesenchymal
• 90-95 % → carcinoma
• 5-10%: carcinoids, lymphoma
• SMOKING RELATED…TOBACCO EPIDEMIC !!! 
polycyclic aromatic hydrocarbons, such as 
benzopyrene, anthracenes, radioactive 
isotopes




Prior WHO 2004 classification
• Tumors other than small cell carcinoma (SCLC) 
lumped together → non-small cell carcinoma 
(NSCLC)
• No theurapetic implication for subtyping
• Light microscopy → only H&E stained
WHO Lung, Thymus and Heart (2015)
Non small cell lung cancer:
• Adenocarcinoma
• Squamous cell carcinoma
• Large cell neuroendocrine (NE) carcinoma
• Neuroendocrine/ Carcinoid tumor: Typical and 
Atypical
• Adenosquamous carcinoma 
• Pleomorphic carcinoma
• Spindle cell carcinoma
• ……..
• Molecular biology and patient treatment
• EGFR gene mutation in lung adenocarcinoma 
→ targeted therapy (gefitinib, erlotinib) →
Significant response
• ALK inhibitor → crizotinib → adenocarcinoma 
with ALK fusion
• Molecular testing for treatment selection in 
lung cancer
WHO Lung, Thymus and Heart (2015)
• Bell DW et al. Epidermal growth factor receptor mutations and gene amplification in nsclc. Molecular analysis of the IDEAL/INTACT gefitinib trials. J Clin Oncol. 2005
• Eberhard DA. Mutations in the egfr and in kras are predictive and prognostic indicators in nsclc treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol 
2005
• Kwak LE et al. Anaplastic lymphoma kinase inhibition in nsclc. NEJM. 2010
Major Genetic Changes in Lung Cancer
“Oncogene Addiction”
• Travis et al. WHO Lung, thymus and heart. 2015.
• Pao W. New driver mutations in non-small lung cancer. Lancet Oncol. 
2011
Adenocarcinoma 
• Def: malignant epithelial tumor with glandular 
differentiation, mucin production or pneumocyte 
marker expression.
• Incidence → Lung cancer trends by histologic type
• Changes in design and characteristic of manufactured 
cigarretes
• Clinical features: variety of symptoms/ no symptoms at 
all. Progressive shortness of breath, cough, chest pain/ 
pressure, hoarseness, loss of voice, hemoptysis.
• Localization: lung periphery
• Adeno markers: TTF1, Napsin A
• Lewis et al. U.S. Lung cancer trends by histologic type. Cancer.2014
• Lewis et al. U.S. Lung cancer trends by histologic type. Cancer.2014
Adenocarcinoma
US Surgeon General’s 2014 report:
1. The evidence is sufficient that the risk of developing 
adenocarcinoma of the lung from cigarette smoking has 
increased since 1960s
2. The evidence is sufficient that the risk of adenocarcinoma 
in smokers results from changes in the design and 
composition of cigarettes since the 1950s
3. The evidence is not sufficient to specify which design 
changes are responsible, suggestive ventilated filters and 
increased levels of tobacco specific nitrosamines
4. The evidence shows that the decline of squamous cell 
carcinoma follows the trend of declining smoking 
prevalence • US public health service office of the surgeon general and national center for chronic disease prevention and 
health promotion. The health consequences of smoking – 50 years of progress. 2014
Adenocarcinoma Cytology
• Travis WD. Diagnosis of lung cancer in small biopsies and cytology. Implications of the 2011 international association 
for study of lung cancer/ American thoracic society/ European respiratory society classification. Arch pathol lab med. 
2013
Adenocarcinoma Histopatology
• Travis WD. Diagnosis of lung cancer in small biopsies and cytology. Implications of the 2011 international association 
for study of lung cancer/ American thoracic society/ European respiratory society classification. Arch pathol lab med. 
2013
Squamous cell carcinoma
• Def: malignant epithelial tumor shows 
keratinization and/or intercellular bridges 
• Clinical features: similar to adenocarcinoma 
• Localization: arise in main or lobar bronchus
• Squamous marker: p40, p63, CK5/6
Squamous cell carcinoma
• Travis WD. Diagnosis of lung cancer in small biopsies and cytology. Implications of the 2011 international association 
for study of lung cancer/ American thoracic society/ European respiratory society classification. Arch pathol lab med. 
2013
Small Cell Lung Cancer (SCLC)
• Small cells, scant cytoplasm, ill defined cell 
border, finely granular chromatin, 
inscopicuous nucleoli
• Expression neuroendocrine marker
• Hilar/ perihilar mass, lymphadenopathy (+)
Terima kasih…
